The global digital pathology market was valued at $735.75 million in 2020, and is expected to reach $1791.30 million by 2030, registering a CAGR of 9.3%, registering a CAGR of 9.3% from 2021 to 2030. Digital pathology is a computer-enabled, image-based information platform that helps for the management of information generated from digital slides.. Digital pathology solution offers scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.
The affordable cost of digital pathology products, convenience of virtual slide transportation, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. Furthermore, the market is being driven by an increase in usage of digital pathology solutions as compared to conventional pathology diagnosis. In addition, developing technologies in digital pathology systems, such as digital microscopy, are important tools in surgical pathology. Increase in interest among pathologists for diagnostic, educational and research purposes increases the usage of digital pathology systems in drug discovery. These aforementioned factors have fueled the market growth. On the contrary, high cost associated with digital pathology systems restrains the market growth. However, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.
According to the data published by Journal of Clinical Medicine, digital pathology is becoming a mainstream option for routine diagnostics. Faster whole slide image scanning is the main way for this development and implementation of new technologies in digital pathology systems. These advantages associated with digital pathology system boost the market growth. In addition, as per the Journal of Pathology, the digital pathology provides greater accuracy and standardization of pathology based trial criteria. The digital pathology platforms improve the training and performance of clinical trial pathologists. Furthermore, increase in number of teleconsultations and rise in adoption of digital pathology systems to enhance lab efficiency drives the growth of the digital pathology market.
According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, around 19.3 million cases of cancer were estimated. According to The World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low & middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of digital pathology market.
In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, and rise in global prevalence of targeted diseases along with surge in geriatric population, are factors that are anticipated to drive the growth of the digital pathology market.
On the contrary, high cost of implementation of digital pathology systems &maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects of radiation emitted from digital pathology systems can lead to cancer as well hinder the growth of the market.
Emerging markets and extensive R&D to build effective digital pathology systems, innovation of various systems, and unmet demand for digital pathology systems in the underdeveloped & developing countries are projected to provide substantial growth opportunities for key players in the digital pathology market.
The digital pathology market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is classified into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, the market is fragmented into educational, clinical, and pharma & biotech companies. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) ,and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global digital pathology market are 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.
The affordable cost of digital pathology products, convenience of virtual slide transportation, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. Furthermore, the market is being driven by an increase in usage of digital pathology solutions as compared to conventional pathology diagnosis. In addition, developing technologies in digital pathology systems, such as digital microscopy, are important tools in surgical pathology. Increase in interest among pathologists for diagnostic, educational and research purposes increases the usage of digital pathology systems in drug discovery. These aforementioned factors have fueled the market growth. On the contrary, high cost associated with digital pathology systems restrains the market growth. However, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.
According to the data published by Journal of Clinical Medicine, digital pathology is becoming a mainstream option for routine diagnostics. Faster whole slide image scanning is the main way for this development and implementation of new technologies in digital pathology systems. These advantages associated with digital pathology system boost the market growth. In addition, as per the Journal of Pathology, the digital pathology provides greater accuracy and standardization of pathology based trial criteria. The digital pathology platforms improve the training and performance of clinical trial pathologists. Furthermore, increase in number of teleconsultations and rise in adoption of digital pathology systems to enhance lab efficiency drives the growth of the digital pathology market.
According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, around 19.3 million cases of cancer were estimated. According to The World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low & middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of digital pathology market.
In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, and rise in global prevalence of targeted diseases along with surge in geriatric population, are factors that are anticipated to drive the growth of the digital pathology market.
On the contrary, high cost of implementation of digital pathology systems &maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects of radiation emitted from digital pathology systems can lead to cancer as well hinder the growth of the market.
Emerging markets and extensive R&D to build effective digital pathology systems, innovation of various systems, and unmet demand for digital pathology systems in the underdeveloped & developing countries are projected to provide substantial growth opportunities for key players in the digital pathology market.
The digital pathology market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is classified into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, the market is fragmented into educational, clinical, and pharma & biotech companies. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) ,and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global digital pathology market are 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global digital pathology market to identify the prevailing opportunities
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies
- Comprehensive analysis of factors that drive and restrict the market growth is provided
- Region- & country-wise analysis is provided to understand the market trends and dynamics
KEY MARKET SEGMENTS
By Product Type
- Scanners
- Software
- Storage & Communication Systems
By Application
- Teleconsultation
- Disease Diagnosis
- Drug Discovery
- Training & Education
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- 3DHISTECH Ltd
- Danaher Corporation
- Glencoe Software Inc
- HAMAMTSU Photonics KK
- Indica Labs Inc
- Koninklijke Philips NV
- Nikon Corporation
- Perkinelmer Inc
- Roche
- VisoPharma A/S
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Digital Pathology Market, by Product
Chapter 5: Digital Pathology Market, by Application
Chapter 6: Digital Pathology Market, by End-user
Chapter 7: Digital Pathology Market, by Region
Chapter 8: Competitive Landscape
Chapter 9: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Digital Pathology Market by Type, Application Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,the digital pathology market was valued at $735.75 million in 2020, and is estimated to reach $1791.30 million by 2030, growing at a CAGR of 9.3% from 2021 to 2030.Digital pathology is an emerging technology in the field of pathology, where test results are converted into digital images for easy viewing, analysis, storage, and management of the collected data. This is expected to result in many advancements and upgradation of conventional pathology. It introduced whole slide imaging technologies, which enabled the digitalization of an entire specimen at diagnostic quality improves laboratory workflow. Digital pathology is rapidly gaining momentum as an essential technology with specific support for education, drug discovery & tissue based research, and practice of human pathology throughout the world. Thus, lack in number of pathologists globally is addressed by the use of digital pathology, which is the major benefit of this technology. In addition, increase in applications of digital pathology for disease consultation, especially for cancer, boosts the market growth. The other key factors contributing to the growth of this market are rise in prevalence of chronic diseases and convenience in virtual transportation of slides
Increase in prevalence of cancer cases and rise in adoption of new digital pathology systems boost the growth of the market. For instance, in March 2018, F-Hoffmann La-Roche Ltd. announced the launch of VENTANA DP 200 Slide scanner for digital pathology. The scanner is used to produce images with high quality. In addition, in January 2018, Inspirata acquired the company Omnyx from GE healthcare. This acquisition ensured that Inspirata provided one of the most comprehensive digital pathology solutions. Thus, rise in innovations of new digital pathology systems propels the market growth
Furthermore, increase in number of teleconsultations; rise in applications in drug discovery; surge in usage in diagnosis of chronic diseases; increase in use by physicians & scientists for working in various fields such as oncology, medical anatomic pathology, and preclinical toxicology enhance the growth of the market. According to CrownBio Blog, digital pathology is involved in the analysis of tissue samples by trained pathologists. While the work flow of digital pathology is a gold standard for the diagnosis of many diseases which includes cancer. Moreover, implementation of powerful AI technology combined with digital pathology system, and surge the usage in cancer drug discovery drive the growth of the digital pathology market.
Thus, these aforementioned factors are anticipated to drive the growth of the digital pathology market. In addition, initiatives taken by governments to ensure early diagnosis and symptoms of disorders and improvement in development of innovative technologies in the healthcare sector thereby propelling the growth of the market.
On the basis of product type, the scanners segment is expected to register significant growth rate during the forecast period, owing to the benefits offered by digital pathology scanners such as it aids in analyzing multitude of images with ease and in studying complex morphologies & features of soft tissues. In addition, these systems perform repeated data analysis across experiments and produce images with high resolution. Moreover, recent approvals granted by FDA boost the growth of digital pathology scanners market.
On the basis of application, the disease diagnostics segment will show significant growth, owing to growth in number of research activities and increase in adoption of digital scanning among the pharmaceutical and biopharmaceutical companies.
On the basis of end users, the pharma & biotech companies segment accounted for the largest share in the global digital pathology market, as it delivers well-organized, documented, retrieved, and logistical pathological procedures. However, clinical segment will show fastest market growth due to rise in number of clinics incorporating digital pathology over traditional pathology, which in turn ,fuels the market growth.
North America accounted for a majority of the global digital pathology market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic diseases, consumer awareness for early diagnosis, presence of key players, increase in healthcare expenditure, advancements in application, and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in incidences of cancer, surge in demand for healthcare services from an aging population, and increase in investments in healthcare sector in the region.
Key Findings Of The Study
- On the basis of type, the scanners segment was the highest contributor to the market in 2020
- On the basis of application type, the disease diagnosis segment dominated the market in 2020, and is expected to continue this trend during the forecast period
- On the basis of end user, the pharma & biotech companies segment was the highest contributor to the market in 2020
- On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest 106% CAGR during the forecast period
- North America dominated the digital pathology market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of cancer, presence of key players, development of the healthcare sector, presence of numerous digital pathology systems, and advancement in technology for digital pathology system in the region Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of inflammatory diseases, improvement in healthcare infrastructure, and technological advancements in digital pathology systems
Companies Mentioned
- 3DHISTECH LTD
- Danaher Corporation
- Glencoe Software Inc.
- HAMAMTSU Photonics K.K
- Indica Labs Inc.
- Koninklijke Philips N.V
- Nikon Corporation
- Perkinelmer Inc.
- Roche
- VisoPharma A/S.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 244 |
| Published | February 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 735.75 million |
| Forecasted Market Value ( USD | $ 1791.3 million |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
